US5776182A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Blood contact surfaces employing natural subendothelial matrix and method for making and using the same
Assignee: W.L. Gore and Associates Inc
•
Filing: 1996-12-02
•
Granted: 1998-07-07
•
Expires: 2016-12-02
Abstract
Abstract This invention relates to improved vascular prostheses derived from mammalian blood vessels. The prostheses are fabricated from arterial segments from which the donor endothelium has been removed. A key aspect of this invention is the preservation of the subendothelial extracellular matrix that will serve as the blood interface of the vascular prostheses. The vessel segments are treated to reduce the likelihood of calcification and fixed with a tissue preservative. This invention results in vascular prostheses that are particularly useful for small diameter applications, such as arterial replacement requiring a diameter of 6 mm or less.
Inventors
- 👤 William Carl Bruchman
- 👤 Anita Jean Switzer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 05:43
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/507; A61F; A61F2/00; A61F2/02; A61F2/04; A61F2/06
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
114 words
A blood contact material which comprises: a substratum; a blood contact layer attached to the substratum comprising a preserved subendothelial matrix layer substantially free of donor endothelial cells; wherein the preserved subendothelial matrix layer comprises chondroitin sulfate proteoglycans, fibronectin, collagen, glycosaminoglycan-bearing proteoglycans, and elastin; wherein the preserved subendothelial matrix layer is suitable to serve as a primary blood contact surface; wherein the substratum comprises a tubular blood vessel having an exterior and interior, wherein the exterior of the blood vessel is surrounded by a microporous polymeric sheath, the sheath being permeable to macromolecules, while preventing cell ingrowth across the sheath; and wherein the blood contact surface comprises the interior of the tubular blood vessel.
Claim 2
Dependent Claim
114 words
A blood contact material which comprises: a substratum; a blood contact layer attached to the substratum comprising a preserved subendothelial matrix layer substantially free of donor endothelial cells; wherein the preserved subendothelial matrix layer comprises chondroitin sulfate proteoglycans, fibronectin, collagen, glycosaminoglycan-bearing proteoglycans, and elastin; wherein the preserved subendothelial matrix layer is suitable to serve as a primary blood contact surface; wherein the substratum comprises a tubular blood vessel having an exterior and interior, wherein the exterior of the blood vessel is surrounded by a microporous polymeric sheath, the sheath being permeable to macromolecules, while preventing cell ingrowth across the sheath; and wherein the blood contact surface comprises the interior of the tubular blood vessel.
Claim 3
Dependent Claim
27 words
The blood contact material of claim 1, wherein the collagen is selected from the group consisting of collagen Type I, collagen Type III, and collagen Type IV.
Claim 4
Dependent Claim
53 words
The blood contact material of claim 1 wherein the primary blood contact surface is formed through the following process: providing a subendothelial matrix layer with a layer of endothelial cells attached thereto; stripping the endothelial cell layer from the subendothelial matrix layer to produce a blood contact surface substantially free of endothelial cells.
Claim 5
Dependent Claim
25 words
The blood contact material of claim 3 which further comprises stripping the endothelial layer from the subendothelial matrix layer by treating with a stripping solution.
Claim 6
Dependent Claim
14 words
The blood contact material of claim 4 wherein the stripping solution is ammonium hydroxide.
Claim 7
Dependent Claim
20 words
The blood contact material of claim 3 which further comprises stripping the endothelial layer by freeze-thaw treating the endothelial layer.
Claim 8
Dependent Claim
21 words
The blood contact material of claim 3 which further comprises stripping the endothelial layer by air dry treating the endothelial layer.
Claim 9
Dependent Claim
19 words
The blood contact material of claim 1 wherein the tubular blood vessel is an artery derived from a donor.
Claim 10
Dependent Claim
19 words
The blood contact material of claim 1 wherein the tubular blood vessel is a vein derived from a donor.
Claim 11
Dependent Claim
33 words
The blood contact material of claim 1 wherein the blood vessel is treated to resist calcification and to improve patency performance of the blood contact material with a solution of chloroform and methanol.
Claim 12
Dependent Claim
23 words
The blood contact material of claim 1 wherein the subendothelial matrix layer is treated with a fixative to preserve the subendothelial matrix layer.
Claim 13
Dependent Claim
34 words
The blood contact material of claim 1 wherein the material for the sheath is selected from the group consisting of at least one of polytetrafluoroethylene, polyethylene terepthalate, fluorinated ethylene propylene, polyethylene, polypropylene, and siloxane.
Claim 14
Dependent Claim
14 words
The blood contact material of claim 1 wherein the sheath comprises an expanded polytetrafluoroethylene.
Claim 15
Dependent Claim
36 words
The blood contact material of claim 1 wherein external portions of the tubular blood vessel are enzymatically removed to reduce the outer diameter of the vessel, while the subendothelial matrix layer is protected from enzymatic action.
Claim 16
Dependent Claim
19 words
The blood contact material of claim 14 wherein the tubular blood vessel is an artery derived from a donor.
Claim 17
Dependent Claim
19 words
The blood contact material of claim 14 wherein the tubular blood vessel is a vein derived from a donor.
Claim 18
Dependent Claim
33 words
The blood contact material of claim 14 wherein the blood vessel is treated to resist calcification and to improve patency performance of the blood contact material with a solution of chloroform and methanol.
Claim 19
Dependent Claim
23 words
The blood contact material of claim 14 wherein the subendothelial matrix layer is treated with a fixative to preserve the subendothelial matrix layer.
Claim 20
Dependent Claim
34 words
The blood contact material of claim 14 wherein the exterior of the blood vessel is surrounded by a microporous polymeric sheath, the sheath being permeable to macromolecules while preventing cell ingrowth across the sheath.
Claim 21
Dependent Claim
33 words
The polymeric sheath of claim 19 wherein the material for the sheath is selected from the group consisting of at least one of polytetrafluorethylene, polyethylene terepthalate, fluorinated ethylene propylene, polyethylene, polypropylene, and siloxane.
Claim 22
Dependent Claim
13 words
The polymeric sheath of claim 19 wherein the sheath comprises an expanded polytetrafluoroethylene.
Claim 23
Dependent Claim
74 words
An artificial blood vessel which comprises: a natural subendothelial matrix layer extracted from a donor blood vessel and preserved, the preserved subendothelial matrix layer comprising chondroitin sulfate proteoglycans, fibronectin, collagen, glycosaminoglycan-bearing proteoglycans, and elastin, wherein the preserved subendothelial matrix layer is suitable to serve as a direct blood contact surface; and a sheath comprised of a microporous polymer that is permeable to macromolecules and impermeable to cell ingrowth surrounding the preserved subendothelial matrix layer.
Claim 24
Dependent Claim
74 words
An artificial blood vessel which comprises: a natural subendothelial matrix layer extracted from a donor blood vessel and preserved, the preserved subendothelial matrix layer comprising chondroitin sulfate proteoglycans, fibronectin, collagen, glycosaminoglycan-bearing proteoglycans, and elastin, wherein the preserved subendothelial matrix layer is suitable to serve as a direct blood contact surface; and a sheath comprised of a microporous polymer that is permeable to macromolecules and impermeable to cell ingrowth surrounding the preserved subendothelial matrix layer.
Claim 25
Dependent Claim
106 words
A blood contact material which comprises: a tubular blood vessel derived from a donor having an outer diameter and an inner diameter and an exterior surface and an interior surface, at least a portion of the blood vessel comprising smooth muscle cells; a primary blood contact surface attached to the interior surface of the blood vessel comprising a preserved subendothelial matrix layer substantially free of donor endothelial cells; wherein the outer diameter of the tubular blood vessel is reduced by digestion of external portions of the blood vessel with a proteolytic enzyme; and wherein the primary blood contact surface is not exposed to the proteolytic enzyme.
Claim 26
Dependent Claim
106 words
A blood contact material which comprises: a tubular blood vessel derived from a donor having an outer diameter and an inner diameter and an exterior surface and an interior surface, at least a portion of the blood vessel comprising smooth muscle cells; a primary blood contact surface attached to the interior surface of the blood vessel comprising a preserved subendothelial matrix layer substantially free of donor endothelial cells; wherein the outer diameter of the tubular blood vessel is reduced by digestion of external portions of the blood vessel with a proteolytic enzyme; and wherein the primary blood contact surface is not exposed to the proteolytic enzyme.
Claim 27
Dependent Claim
27 words
The artificial blood vessel of claim 22 wherein the collagen is selected from the group consisting of collagen Type I, collagen Type III, and collagen Type IV.
References Cited (Backward Citations)
US2900644A
Cited
US4187390A
Cited
US3953566A
Cited
US3988782A
Cited
US3927422A
Cited
US4083066A
Cited
US4098571A
Cited
US4383832A
Cited
US4539716A
Cited
US4323358A
Cited
US4546500A
Cited
US5217492A
Cited
WO1984001892A1
Cited
US4960423A
Cited
US4801299A
Cited
US4553974A
Cited
US4671797A
Cited
US4804382A
Cited
US4804381A
Cited
US4776853A
Cited
US5131908A
Cited
US4883755A
Cited
US5192311A
Cited
US5037378A
Cited
WO1994003586A1
Cited
WO1995029714A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-07-06 | 2002-01-05 | 2002-07-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-07-06 | 2006-01-05 | 2006-07-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-07-06 | 2010-01-05 | 2010-07-07 | $7700.00 | Window Closed / Lapsed |